Fetal RhD genotyping: A more efficient use of anti-D immunoglobulin

Transfusion Clinique et Biologique

Volumn 14, Issue 6, 2007, Pages 568-571

  Daniels, G ^a   Finning, K ^a   Martin, P ^a   Summers, J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

antenatal diagnosis; Fetal DNA; Genotyping; Maternal plasma; RhD; Rhesus

Indexed keywords

DNA; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ACCURACY; ARTICLE; DIAGNOSTIC TEST; FEASIBILITY STUDY; GENOTYPE; HUMAN; MATERNAL PLASMA; PREGNANCY;

FEMALE; FETAL BLOOD; FETAL DISEASES; GENOTYPE; HUMANS; ISOANTIBODIES; PREGNANCY; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 43049089321     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.03.007     Document Type: Article

References (22)

1. Daniels G. Human Blood Groups. 2nd ed. (2002), Blackwell Science, Oxford
2. Wagner F.F., and Flegel W.A. RHD gene deletion occurred in the Rhesus box. Blood 95 (2000) 3662-3668
3. Singleton B.K., Green C.A., Avent N.D., Martin P.G., Smart E., Daka A., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype. Blood 95 (2000) 12-18
4. Faas B.H.W., Beckers E.A.M., Wildoer P., Ligthart P.C., Overbeeke M.A., Zondervan H.A., et al. Molecular background of VS and weak C expression in blacks. Transfusion 37 (1997) 38-44
5. Daniels G.L., Faas B.H.W., Green C.A., Smart E., Maaskant-van Wijk P.A., Avent N.D., et al. The Rh VS and V blood group polymorphisms in Africans: a serological and molecular analysis. Transfusion 38 (1998) 951-958
6. Wagner F.F., Gassner C., Müller T.H., Schönitzer D., Schunter F., and Flegel W.A. Molecular basis of weak D phenotypes. Blood 93 (1999) 385-393
7. Westhoff C.M. Rh complexities: serology and DNA genotyping. Transfusion 47 1S (2007) 17S-22S
8. VI category phenotype. Blood 83 (1994) 1129-1135
9. Wilson R.D. Amniocentesis and chorionic villus sampling. Curr Opin Obstet Gynecol 12 (2000) 81-86
10. Tabor A., Bang J., and Nørgaard-Pedersen B. Fetomaternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 94 (1987) 528-534
11. Lo Y.M., Tein M.S.C., Lau T.K., Haines C.J., Leung T.N., Poon P.M.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62 (1998) 768-775
12. van der Schoot C.E., Tax G.H., Rijnders R.J., de Haas M., and Christiaens G.C. Prenatal typing of Rh and Kell blood group antigens: the edge of a watershed. Transfus Med Rev 17 (2003) 32-44
13. Daniels G., Finning K., Martin P., and Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 87 (2004) 225-232
14. Geifman-Holtzman O., Grotegut C.A., and Gaughan J.P. Diagnostic accuracy of noninvasive fetal genotyping from maternal blood - a meta analysis. Am J Obstet Gynecol 195 (2006) 1163-1173
15. Finning K.M., Martin P.G., Soothill P.W., and Avent N.D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42 (2002) 1079-1085
16. Daniels G., Finning K., Martin P., and Summers J. Fetal blood group genotyping. Present and future. Ann N Y Acad Sci 1075 (2006) 88-95
17. Page-Christiaens G.C.M.L., Bossers B., van der Schoot C.E., and de Haas M. Use of bi-allelic insertion/deletion polymorphisms as a positive control in maternal blood. First clinical experience. Ann N Y Acad Sci 1075 (2006) 123-129
18. Chan K.C.A., Ding C., Gerovassili A., Yeung S.W., Chiu R.W., Leung T.N., et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52 (2006) 2211-2218
19. Daniels G., van der Schoot C.E., and Olsson M.L. Report of the first international workshop on molecular blood group genotyping. Vox Sang 88 (2005) 136-142
20. Daniels G., van der Schoot E., and Olsson M.L. Report of the Second International Workshop on molecular blood group genotyping. Vox Sang 93 (2007) 83-88
21. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. Brit Med J 2008; in press and http://www.bmj.com/cgi/content/full/bmj.39518.463206.25.
22. van der Schoot C.E., Soussan A.A., Dee R., Bonsel G.J., and de Haas M. Screening for foetal RHD-genotype by plasma PCR in all D negative pregnant women is feasible. Vox Sang 87 suppl 3 (2004) 9 abstract